Literature DB >> 7213649

Conformation of pardaxin, the toxin of the flatfish Pardachirus marmoratus.

N Primor, A T Tu.   

Abstract

Pardaxin is the toxic component isolated from the secretion of the Red Sea flatfish Pardachirus marmoratus. Pardaxin has attracted considerable attention recently because of its use as shark repellent. Conformational information regarding the peptide backbone, disulfide bonds, and tyrosine chromophores was obtained using Raman and circular dichroism (CD) spectroscopy. Analysis of the Raman spectra indicates that the toxin consists of 39% alpha-helix, 23% beta-structure, and 39% random coil. The occurrence of a band at 510--512 cm-1 indicates the conformational geometry of the disulfide C-C-S-S-C-C linkages to be gauche-gauche-gauche. From the lack of a peak in the 2500--2700 cm-1 region we concluded that all half-cystines are involved in disulfide linkages. The far-ultraviolet CD spectrum of pardaxin showed positive 196 and negative 208 and 222 nm bands. The best fit secondary structure based on the CD ellipticities was found to be: 23% alpha-helix, 21% beta-structure, and 56% random coil. Under highly acidic and alkaline conditions the far-ultraviolet pardaxin spectra showed extensive, reversible loss of its helical structure. Due to certain biological characteristics of pardaxin the possible influence of salt on pardaxin's conformation was examined. No evidence of conformation perturbation was detected in either the CD or Raman spectra of pardaxin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7213649     DOI: 10.1016/0005-2795(80)90124-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Pharyngeal cavity and the gills are the target organ for the repellent action of pardaxin in shark.

Authors:  N Primor
Journal:  Experientia       Date:  1985-05-15

2.  Use of the antimicrobial peptide pardaxin (GE33) to protect against methicillin-resistant Staphylococcus aureus infection in mice with skin injuries.

Authors:  Han-Ning Huang; Chieh-Yu Pan; Yi-Lin Chan; Jyh-Yih Chen; Chang-Jer Wu
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  Pardaxin produces postjunctional muscle contraction in guinea-pig intestinal smooth muscle.

Authors:  N Primor
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

4.  Pardaxin, a fish antimicrobial peptide, exhibits antitumor activity toward murine fibrosarcoma in vitro and in vivo.

Authors:  Shu-Ping Wu; Tsui-Chin Huang; Ching-Chun Lin; Cho-Fat Hui; Cheng-Hui Lin; Jyh-Yih Chen
Journal:  Mar Drugs       Date:  2012-08-22       Impact factor: 6.085

Review 5.  Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress.

Authors:  Ammad Ahmad Farooqi; Kun-Tzu Li; Sundas Fayyaz; Yung-Ting Chang; Muhammad Ismail; Chih-Chuang Liaw; Shyng-Shiou F Yuan; Jen-Yang Tang; Hsueh-Wei Chang
Journal:  Tumour Biol       Date:  2015-07-19

Review 6.  Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2.

Authors:  Tofael Ahmed Sumon; Md Ashraf Hussain; Mahmudul Hasan; Aminur Rashid; Muyassar Hamid Abualreesh; Won Je Jang; S M Sharifuzzaman; Christopher Lyon Brown; Eun-Woo Lee; Md Tawheed Hasan
Journal:  Aquaculture       Date:  2021-04-15       Impact factor: 5.135

7.  Anti-infective Effects of a Fish-Derived Antimicrobial Peptide Against Drug-Resistant Bacteria and Its Synergistic Effects With Antibiotic.

Authors:  Yue Chen; Jing Wu; Honglan Cheng; Yue Dai; Yipeng Wang; Hailong Yang; Fei Xiong; Wei Xu; Lin Wei
Journal:  Front Microbiol       Date:  2020-11-23       Impact factor: 5.640

8.  Mechanisms of peptide-induced pore formation in lipid bilayers investigated by oriented 31P solid-state NMR spectroscopy.

Authors:  Kresten Bertelsen; Jerzy Dorosz; Sara Krogh Hansen; Niels Chr Nielsen; Thomas Vosegaard
Journal:  PLoS One       Date:  2012-10-18       Impact factor: 3.240

9.  Antimicrobial peptides from fish.

Authors:  Jorge A Masso-Silva; Gill Diamond
Journal:  Pharmaceuticals (Basel)       Date:  2014-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.